Synopsys (SNPS) Research & Development (2009 - 2026)

Synopsys has reported Research & Development for 18 years, with the latest figure at $715.0 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 29.24% year-over-year to $715.0 million; the trailing twelve-month figure through Jan 2026 stood at $2.6 billion (up 25.17% YoY), and the FY2025 full-year result was $2.5 billion, up 19.06% from the prior year.
• Research & Development for Q1 2026 stood at $715.0 million, down from $746.8 million in the prior quarter.
• The five-year high for Research & Development was $746.8 million in Q4 2025, with the low at $371.1 million in Q4 2022.
• Historically, Research & Development has averaged $514.3 million across 5 years, with a median of $493.1 million in 2024.
• Annual changes were most pronounced in 2022 — Research & Development dropped 10.34% — and 2025, when it surged 34.61%.
• Synopsys' Research & Development stood at $371.1 million in 2022, then increased by 25.53% to $465.8 million in 2023, then grew by 19.11% to $554.8 million in 2024, then surged by 34.61% to $746.8 million in 2025, then declined by 4.27% to $715.0 million in 2026.
• The last three Research & Development figures came in at $715.0 million (Q1 2026), $746.8 million (Q4 2025), and $625.3 million (Q3 2025), per Business Quant data.